A Comparison Between Paclitaxel-eluting Balloon in Combination With BMS Implantation vs Conventional Balloon and DES Implantation
Phase 4
Terminated
- Conditions
- Myocardial Ischemia
- Interventions
- Device: DEB+BMSDevice: POBA+DES
- Registration Number
- NCT01637896
- Lead Sponsor
- Leonardo Bolognese, MD
- Brief Summary
The purpose of this study is to evaluate the efficacy of predilation with paclitaxel-eluting balloon and bare metal stent implantation VS conventional balloon and drug-eluting stent implantation in terms of restenosis
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
- age> 18 years
- angina or stress test positive for ischemia
- de novo coronary stenosis>50%
Exclusion Criteria
- recent myocardial infarction (<72h)
- severe chronic kidney disease
- allergy to Paclitaxel
- contraindication for combined antiplatelet treatment
- life expectancy <1 year
- hypersensitivity or contraindication to one of the study drugs
- lack of consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description DEB+BMS DEB+BMS drug-eluting balloon predilation and bare metal stent implantation POBA+DES POBA+DES conventional balloon predilation and drug-eluting stent implantation
- Primary Outcome Measures
Name Time Method angiographic binary re-restenosis 9 months incidence of angiographic binary re-restenosis
- Secondary Outcome Measures
Name Time Method Late luminal loss 9 months incidence of late luminal loss assessed by angiography
major adverse cardiac events 12 months incidence of major adverse cardiac events
Trial Locations
- Locations (1)
Cardiovascular Department, Ospedale S.Donato
🇮🇹Arezzo, AR, Italy